Inhibition of PCSK9 reduces infarct size and arrhythmia susceptibility in cardiac ischeamia/reperfusion injury through attenuating mitochondrial dysfunction and increasing connexin43 phosphorylation
28 August 2018 (09:24 - 09:42)
Organised by:
About the speaker
Maharaj Nakorn Chiang Mai Hospital, Chiang Mai (Thailand)
4 More presentations in this session
Doctor U. Kassner (Berlin, DE)
Professor P. Sever (London, GB)
Access the full session
The Event
ESC Congress 2018
28 August 2018
09:24 CET
